FONTANA DILETTA

Pubblicazioni

  • (2019). Characterization of the role of mutated ETNK1 in the onset of atypical Chronic Myeloid Leukemia. (Tesi di dottorato, Università degli Studi di Milano-Bicocca, 2019). Dettaglio
  • Magistroni, V., Mauri, M., D'Aliberti, D., Mezzatesta, C., Crespiatico, I., Nava, M., et al. (2019). De novo UBE2A mutations are recurrently acquired during chronic myeloid leukemia progression and interfere with myeloid differentiation pathways. HAEMATOLOGICA. Dettaglio
  • Fontana, D., Mauri, M., Niro, A., Massimino, L., Bertagna, M., Zambrotta, G., et al. (2018). ETNK1 mutations promote ROS production and DNA damage through increased mitochondrial activity. In Proceedings: AACR Annual Meeting 2018. Dettaglio
  • Mah, S., Park, J., Jung, H., Ahn, K., Choi, S., Tae, H., et al. (2018). Correction to Identification of 4-Phenoxyquinoline Based Inhibitors for L1196M Mutant of Anaplastic Lymphoma Kinase by Structure-Based Design. JOURNAL OF MEDICINAL CHEMISTRY, 61(5), 2131-2131. Dettaglio
  • Fontana, D., Mauri, M., Niro, A., Massimino, L., Bertagna, M., Zambrotta, G., et al. (2018). ETNK1 MUTATIONS INCREASE MITOCHONDRIAL ACTIVITY AND PROMOTE DNA DAMAGE THROUGH ROS PRODUCTION. Intervento presentato a: XV Congress of the Italian Society of Experimental Hematology, Rimini, Italy. Dettaglio